Today's ESA/Hubble Picture of the Week features a galaxy that Hubble has captured multiple times over more than 20 years. The ...

Cepheid variable stars, pulsating stars with varying brightness and size, are crucial for determining astronomical distances, as exemplified by Edwin Hubble's Andromeda Galaxy measurement. The Leavitt ...

Sherlock Biosciences has teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech for new tests on the latter’s automated laboratory systems. The collaboration will focus on ...

SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...

SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...

Cepheid ($CPHD), despite modest growth in revenue, landed in the red for the fourth quarter of 2013 largely due to restructuring costs. Reported revenue for Q4 2013 ...

Cepheid Management to Present at the 7th Annual Needham Medical Technology and Biotechnology Conference and William Blair's 28th Jun 4, 2008 10:21am Providers ...

Collaborators believe that quantitative detection of HPV viral load is indicative of disease risk. Cepheid will exclusively license Quantovir’s HPV patent portfolio to develop a diagnostic for ...

Danaher Corp. (IW 500/55) agreed to buy molecular diagnostics company Cepheid in a deal valued at about $4 billion, including debt, the first purchase since spinning off its industrial businesses to ...